Companies 0 See All
Hedge Funds 0 See All
Insiders 0 See All
Institutional Investors 0 See All
Click here to see all results for
Home > Insider Trading > T. Keith Flaherty > Profile

T. Keith Flaherty

Affiliations

  • at Kinnate Biopharma Inc. (KNTE), 2024-04-05
  • Director at Checkmate Pharmaceuticals Inc. (CMPI), 2022-05-31
  • Director at Clovis Oncology Inc. (CLVS), 2021-06-12
  • Director at Loxo Oncology Inc. (LOXO), 2019-02-15
Insider Trading: Sales See All
Symbol Price Amount Total Value Remaining Holdings Date Form 4
LOXO $175.97 5,422 $954,115.85 9,732 2018-06-07 Filing
LOXO $175.10 4,743 $830,501.20 15,154 2018-06-07 Filing
LOXO $174.04 16,037 $2,791,153.25 19,897 2018-06-07 Filing
LOXO $173.32 12,243 $2,121,981.25 35,934 2018-06-07 Filing
LOXO $172.03 4,634 $797,209.26 48,177 2018-06-07 Filing